January 29, 2026
What Medicare Drug Negotiation Means for Patients in 2026 and Beyond
As we rang in the new year, we passed a significant milestone in the Medicare Negotiation Program. Quietly and without…
Read MoreJanuary 27, 2026
CCPA Responds to CMS Drug Price Negotiation Announcement (IPAY 2028)
Liz Helms, Founder and Director of the Chronic Care Policy Alliance (CCPA), issued the following statement in response to the…
Read MoreJanuary 21, 2026
CCPA Submits Letters to Congress Ahead of Insurance Hearings
Today, the Chronic Care Policy Alliance (CCPA) submitted two letters to congressional committees ahead of hearings examining insurance practices and…
Read MoreDecember 22, 2025
CCPA Statement on Medicare GLOBE and GUARD Rules
Liz Helms, CEO of the Chronic Care Policy Alliance (CCPA), issued the following statement following the release by the Centers…
Read MoreDecember 16, 2025
Why PBM Reform Must Be a Priority in 2026
Pharmacy Benefit Managers (PBMs) sit at the center of the prescription drug supply chain, and for years, patients have felt…
Read MoreDecember 11, 2025
RECAP: CCPA’s Washington, D.C. Advocacy Trip
At the end of October, CCPA Chief Executive Officer (CEO), Liz Helms, traveled to Capitol Hill in Washington, D.C., for…
Read MoreNovember 26, 2025
CCPA Supports Bipartisan RESULTS Act to Protect Medicare Diagnostic Testing
CCPA recently signed on, along with 29 other patient organizations, to a national advocacy letter led by RetireSafe urging Congress to…
Read MoreNovember 20, 2025
The Hidden Middleman Affecting Your Lab Tests: What You Need to Know About Laboratory Benefit Managers (LBMs)
As states across the country, including California this year, begin to rein in Pharmacy Benefit Managers (PBMs), and U.S. Congress…
Read MoreNovember 3, 2025
CCPA Leads Sign-On Letter Urging Congress to Reinstate Medicare Telehealth Flexibilities
The Chronic Care Policy Alliance (CCPA), joined by more than 50 partner organizations, submitted the following letter to Congressional leadership…
Read MoreOctober 17, 2025
Webinar Recap: Medicare in Transition: Drug Pricing Negotiation, Open Enrollment Essentials, and Legislative Updates
On October 3, 2025, CCPA hosted a webinar, “Medicare in Transition: Drug Pricing Negotiation, Open Enrollment Essentials, and Legislative Updates.”…
Read MoreOctober 13, 2025
Making the Most of Open Enrollment: Your Guide to Medicare Changes, Coverage Choices and More
The shift to cooler weather, the kids going back to school and the sudden need for a flu vaccine are…
Read MoreOctober 10, 2025
CCPA Joins Call to Strengthen Medicare Osteoporosis Care
CCPA recently signed on to an important advocacy letter led by the Bone Health and Osteoporosis Foundationto that was submitted…
Read MoreOctober 8, 2025
Time for 340B Reform: Why Patients Need the 340B ACCESS Act
The 340B Drug Pricing Program was designed to make prescription medications and healthcare services more affordable for uninsured and low-income…
Read MoreOctober 6, 2025
Statement from the Chronic Care Policy Alliance on the Expiration of Telehealth Flexibilities
The Chronic Care Policy Alliance (CCPA) urges Congress to come together in a bipartisan manner to immediately extend Medicare’s telehealth…
Read MoreAugust 1, 2025
340B Bill Successfully Halted in California for 2025
In California, as in many states, a bill expanding the 340B program — AB 1460 — was causing deep concerns…
Read More